This PMP22 Cell Based ELISA Kit allows for the detection of PMP22 and the effects that certain stimulation conditions have on PMP22 expression in different cell lines. Qualitative determination of PMP22 concentration is achieved by an indirect ELISA format. In essence, the PMP22 is captured by Anti-PMP22 Antibodies which in turn are detected by HRP-conjugated secondary antibodies. Through this binding, the HRP enzyme (conjugated to the secondary antibody) can catalyze a colorimetric reaction upon substrate addition. Due to the qualitative nature of this PMP22 Cell Based ELISA Kit, multiple normalization methods are described: 1) Anti-GAPDH Antibody is included to serve as an internal positive control in normalizing the target absorbance values. 2) Following the colorimetric measurement of HRP activity via substrate addition, the Crystal Violet whole-cell staining method is used to determine cell density. After staining, the results can be analyzed by normalizing the absorbance values to cell amounts, by which the plating difference can be adjusted.
Plate-forme
Microplate
Méthode de détection
Colorimetric
Type d'échantillon
Adherent cells and suspension cells.
Gamme de detection
> 5000 Cells
Durée du test
4 hours 30 minutes
Reactivité
Human, Mouse, Rat
Precision
Intra-assay CV: < 8%, Inter-assay CV: < 10%
Stockage
Store at + 4°C. Stable for 6 months.
Synonymes
CMT1A, CMT1E, DSS, GAS-3, GAS3, Growth Arrest Specific 3, Growth arrest-specific protein 3, HMSNIA, HNPP, MGC20769, Peripheral myelin protein 22, PMP-22, PMP22_HUMAN, Sp110, Trembler
Avertissement
Ce produit est uniquement destiné à la recherche. Il n'est pas destiné à un usage diagnostique ou thérapeutique.
Figure 4: Western Blot - PMP22 Cell Based ELISA Kit (CB5579)
The mouse monoclonal antibody to GAPDH is used as a positive control inPMP22 Cell Based ELISA Kit. Anti-GAPDH Antibody was tested for specificity by western blot with tissue lysates from human, mouse, and rat.
